PROVIDER PROFILE · NPI 1952625592
Catherine PollardPA-C
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
5,320
Unique beneficiaries
—
Total services
9,769
Distinct HCPCS
21
Medicare payment
$319K
PRESCRIBING · PART D · 2024
Total Rx claims
1,757
Beneficiaries
—
Total drug cost
$757K
Distinct drugs
27
Brand share
10.6%
Top prescribed drugs
Ketoconazole317 claims
Clobetasol Propionate301 claims
Triamcinolone Acetonide164 claims
Metronidazole112 claims
Hydroxyzine Hcl88 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
100.0
Cost
87.9
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
1.05%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$2K
Payment records
119
By payment type
Food and Beverage$2K
Education$87
Top paying entities
Food and Beverage$2K
Education$87
REFERRAL NETWORK
Where Catherine Pollard's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Christopher Flye Diagnostic Radiology · New Bern, NC | 38 | 78 |
| James Polo Dermatology · New Bern, NC | 23 | 43 |
| Sean Murphy Dermatology · New Bern, NC | 16 | 34 |
| SOLSTAS LAB PARTNERS GROUP LLC | 14 | 32 |
| TAYLOR, JEFFREY | 12 | 14 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE